Atlas Trials

B-cell Lymphomas

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch B-cell Lymphomas

RecordFirmDate
Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas (NCT03920631)Ahmed Galal, MD2020-07-10
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product (NCT02840110)Cogent Biosciences, Inc.2016-10-01
Safety, Tolerability and PK of BTK Inhibitor DTRMWXHS-12 in Patients With B-Cell Lymphomas (NCT02891590)Zhejiang DTRM Biopharma2016-09-01
CD22 Redirected Autologous T Cells for ALL (NCT02650414)University of Pennsylvania2016-01-13
A Study to Evaluate Safety, Tolerability, PK and PD of HLX01 in Patients With CD20-positive B-cell Lymphomas (NCT03218072)Shanghai Henlius Biotech2014-05-04
AZD6738 First Time in Patient Multiple Ascending Dose Study (NCT01955668)AstraZeneca2013-11-01
Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies (NCT01744912)TG Therapeutics, Inc.2012-11-21
Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients (NCT01613300)Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea2012-04-04
Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL) (NCT01068392)Dong-A University Hospital2009-10-01
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen (NCT01478269)Fondazione Italiana Linfomi - ETS2009-05-01
High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement (NCT00801216)Andrés José Maria Ferreri2007-01-01

Track B-cell Lymphomas automatically

Every clearance here is in the API, with alerts when new ones post.